Cefepime restriction improves gram-negative overall resistance patterns in neonatal intensive care unit

Brazilian Journal of Infectious Diseases

Volumn 11, Issue 2, 2007, Pages 277-280

  de Araujo, Orlei Ribeiro ^a,b   da Silva, Dafne Cardoso Bourguignon ^a   Diegues, Ana Regina ^a   Arkader, Ronaldo ^a   Cabral, Eloíza Aparecida Ferreira ^a   Afonso, Marta Rodriguez ^a   Louzada, Maria Eduarda ^a   Albertoni, Andrea de Cassia Stefano ^a  

^a Hospital e Maternidade Santa Marina   (Brazil)

^b NONE   (Brazil)

Author keywords

Bacterial; Cefepime; Drug resistance; Infection control

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFEPIME; CEPHALOSPORIN; MEROPENEM; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIUM ISOLATE; BIRTH WEIGHT; CONTROLLED STUDY; DRUG USE; GESTATIONAL AGE; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HOSPITAL INFECTION; HUMAN; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; NEWBORN; NEWBORN INFECTION; NEWBORN INTENSIVE CARE; NONHUMAN; PREMATURITY; PREVALENCE;

EID: 34547097515     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1413-86702007000200022     Document Type: Article

References (20)

1. Turner J.P. Extended -spectrum b-lactamases. Clin Infect Dis 2005; 41(4):S273-5.
2. Agnihotri N., Kaistha N., Gupta V. Antimicrobial susceptibility of isolates from neonatal septicemia. Jpn J Infect Dis 2004;57:273-5.
3. Szabó D., Filetóth Z., Szentandrássy J., et al. Molecular epidemiology of a cluster of cases due to Klebsiella pneumoniae producing SHV-5 extended-spectrum β-lactamase in the premature intensive care unit of a Hungarian hospital. J Clin Microbiol 1999;37(12):4167-9.
4. Lee N.C., Chen S.J., Tang R.B., Hwang B.T. Neonatal bacteremia in a neonatal intensive care unit: analysis of causative organisms and antimicrobial susceptibility. J Chin Med Assoc. 2004;67(1):15-20.
5. Calil R., Marba S.T., von Nowakonski A., Tresoldi A.T. Reduction in colonization and nosocomial infection by multiresistant bacteria in a neonatal unit after institution of educational measures and restriction in the use of cephalosporins. Am J Infect Control 2001; 29(3):133-8.
6. Courvalin P. Antimicrobial drug resistance: Prediction is very difficult, specially about the future. Emerg Infect Dis 2005; 11(10):1503-6.
7. McGowan J.E. Do intensive hospital antibiotic control programs prevent the spread of antibiotic resistance? Infect Control Hosp Epidemiol 1994;15(7):478-83.
8. Goldstein F.W. Cephalosporinase induction and cephalosporin resistance: a longstanding misinterpretation. Clin Microbiol Infect 2002:8(12):823-5.
9. Bland J.M., Altman D.G. Survival probabilities (the Kaplan-Meier method). BMJ 1998;317:1572-3.
10. Bland J.M., Altman D.G. The logrank test. BMJ 2004;328:1073.
11. NCCLS. Performance standards antimicrobial susceptibility testing. Document M100-S11. NCCLS, Wayne (PA), 2001.
12. Kaye K.S., Cosgrove S., Harris A., Eliopoulos G., Carmeli Y.Risk factors for emergence of resistance to broad spectrum cephalosporins among Enterobacter spp. Antimicrob Agents Chemoter 2001;45(9):2628-30.
13. Kwak Y.G., Choi S., Choo E.J., Chung J.W., Jeong J., Kim N.J, et al. Risk factors for the acquisition of carbapenem-resistant Klebsiella pneumoniae among hospitalized patients. Microb Drug Resist 2005; 11(2):165-9.
14. Jacobson K.L., Cohen S.H., Inciardi.F., et al. The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I beta-lactamase-producing organisms Clin Infect Dig 1995;21(5):1107-13.
15. Yang Y.J., Livermore D.M. Chromosomal beta-lactamase expression and resistance to beta-lactam antibiotics in Proteus vulgaris and Morganella morganii. Antimicrob Agents Chemother 1988; 32(9):1385-91
16. Fung-Tomc J.C., Gradelski E., Huczko E., et al. Differences in the resistant variants of Enterobacter cloacae selected by extended-spectrum cephalosporins. Antimicrob Agents Chemother 1996;40(5):1289-93.
17. Bradley S.J., Wilson A.L., Allen M.C., et al. The control of hyperendemic glycopeptide-resistant Enterococcus spp. on a haematology unit by changing antibiotic usage. J Antimicrob Chemother 1999;43(2):261-6.
18. Livermore D.M. Minimising antibiotic resistance. Lancet Infect Dis 2005;5(7):450-9.
19. Rice L.B., Hutton-Thomas R., Lakticova V., et al. Beta-lactam antibiotics and gastrointestinal colonization with vancomycin-resistant enterococci. J Infect Dis 2004;189(6):1113-8
20. Rahal J.J., Urban C., Horn D., et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial. Klebsiella. JAMA 1998;280(14):1233-7.